KinDex Pharmaceuticals is a developer of novel therapeutics used to help patients suffering from metabolic disorders.
Business Model:
Revenue: $0
Employees: 1-10
Address:
City: Seattle
State: Washington
Zip:
Country: United States
KinDex Pharmaceuticals is a developer of novel therapeutics used to help patients suffering from metabolic disorders. It was established to focus on the discovery and development of molecules that improve women’s health and impact chronic disease. KinDex Pharmaceuticals is developing therapeutics that work through the Bitter Taste Receptors (TAS2Rs), a family of GPCR receptors that target inflammation and metabolic dysfunction.
Contact Phone:
Contact Email:
Announced Date | Company | Transaction | Money Raised |
---|
Announced Date | Transaction | Number of Investors | Money Raised | Lead Investors | 8/2016 | Debt Financing | $327.3k | 3/2015 | Series A | 3 | $5.5M |
Jeff Katke Jeffrey Bland Polaris Partners Jeff Katke Jeffrey Bland Polaris Partners |
---|
Announced Date | Name | Price |
---|
|
Revenue: 0 - 100000 Employees: Industry: Software |
Details
|
|
Revenue: 0 - 100000 Employees: 51 - 500 Industry: Education |
Details
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Blockchain |
Details
|
|
Revenue: 0 - 100000 Employees: 11 - 50 Industry: Industrial |
Details
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Advertising |
Details
|